Multiple Sclerosis International Federation
My World of MS
online community		 | resize text | home |

National support About MS Get Involved Life with MS Research Resources News About MSIF  
 National support   About MS   Get Involved   Life with MS   Research   Resources   News   About MSIF 
 
Research
Donate advanced search
print version print this page
 

inside
Research:
MS Research News
ECTRIMS 2011
MS Research Database
MSIF research awards
MSIF research projects
Clinical Trials
Stem cells

 
  Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

summary: This study compared treatment with beta-interferon and glatiramer acetate in people with relapsing-remitting MS. No differences were found between the two treatments.

authors: Mikol DD, Barkhof F, Chang P, Coyle PK, Jeffery DR, Schwid SR, Stubinski B, Uitdehaag BM; on behalf of the REGARD study group

source: Lancet Neurol. 2008 Sep 10. [Epub ahead of print]

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary:

    ACE
    Beta-interferon
    Glatiramer
    Interferon
    Multiple sclerosis
    Randomised
    Relapsing/remitting MS
    Sclerosis
    Subcutaneous
Copyright &<br>Link Policy Copyright &
Link Policy 		Privacy Policy Privacy Policy back to top
Disclaimer Disclaimer Acknowledgements Acknowledgements
back to top  back to top  
Email Update Email Update Edit User Details Edit User Details Feedback Feedback Glossary Glossary Site Map Site Map
Back to top Back to top